Provider review
BloomWell Rx review
Three unrelated products carry the same monthly figure.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$199/mo semaglutide, $249/mo for the dual agonist
Visit BloomWell RxIt handles the branded route more honestly than most, charging a stated consultation fee and pricing no drug.
Price as published
BloomWell Rx
$199/mo semaglutide, $249/mo for the dual agonist
- Vs median
- $24/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Three of the four products here cost the same, and they are not similar things: a dual-agonist GLP-1, an NAD+ line and glutathione all carry one figure. That convergence tells you what it usually tells you — what is being priced is the plan and the service around it rather than the compound itself, so choosing between those three is a clinical question rather than a financial one. The branded side is handled better than most of this category. Rather than quoting a monthly number that turns out to exclude the medication, the page charges a stated consultation fee and prices no drug at all, which makes the split explicit instead of leaving you to discover it. A free visit is offered on the compounded lines. Everything published is a floor, so none of these figures is what a working dose costs, and no milligram appears anywhere on the site.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the consultation fee separated from the medication rather than blended
- You want a free visit before committing on the compounded route
- You want several products from one provider on one page
Look elsewhere if
- You expect the price to reflect the compound rather than the plan
- You want a rate rather than a starting point
- You want a dose behind the number
What it actually costs
Price as published
$199/mo semaglutide, $249/mo for the dual agonist
- Vs median
- $24/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Three unrelated products at one figure means the plan is being priced rather than the compound, so choosing between them is a clinical decision and not a financial one. The branded route is separated honestly — a stated consultation charge and no drug price — rather than blended into a monthly figure that turns out to exclude the medication. No low-dose product; all figures floors; no dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Separates the branded consultation fee from the medication rather than blending them.
- Offers a free visit on the compounded lines.
- Four products priced on one page without an intake.
Pharmacy, labs and oversight
BloomWell Rx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What BloomWell Rx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Three of the four products here cost the same, and they are not similar things — a dual-agonist GLP-1, an NAD+ line and glutathione all carry one figure. That convergence is informative in the way it usually is: what is being priced is the plan and the service, not the compound, so choosing between those three is a clinical question rather than a financial one. The branded side is handled better than most. Rather than quoting a monthly figure that turns out to exclude the drug, the page charges a stated consultation fee and prices no medication, which at least makes the split explicit. Everything published is a floor, so none of these figures is what a working dose costs, and no milligram appears anywhere on the site.
The honest cons
Three unrelated products share one figure, so the price reflects the plan and not the compound.
- All figures are floors introduced by starts at.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
BloomWell Rx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way BloomWell Rx does. Both are partners: we may earn a commission if you start care through these links.
Partner
Strut Health
$99/mo sema lozenge (auto-refill)
Standard plan, self-directed low dose
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
Partner
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
Standard plan, self-directed low dose
Where this sits
#327 of 548
Ordered with the companies that pay us first, and BloomWell Rx is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $15/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.